Related Articles
DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas
DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma
Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma
DEK modulates both expression and alternative splicing of cancer‑related genes